Vancouver, BC – May 25-26, 2019
Whether the result of injury or surgery, wounds must undergo the healing process in order to restore skin health and integrity. Many factors can disrupt one or more phases of this process, resulting in non-healing wounds and abnormal scarring – the impacts of which can have devastating physical, emotional, and financial consequences. Optimizing wound healing and scar reduction is thus a major consideration among healthcare professionals.
Divided into a 1 ½ day seminar program and ½ day laboratory training, this live event provides healthcare professionals foundational knowledge on wound and scar physiology, proven clinical approaches in wound and scar assessment, current treatment recommendations and guidelines, and peer-reviewed evidence on personalized approaches toward- and pharmaceutical compounding opportunities for- the treatment of wounds and scars.
Through case studies, formulation activities, and interactive discussions, the 1 ½ day seminar component of this live event investigates:
- Wound healing and scar formation physiology.
- Clinical decision-making processes for wound and scar assessment and management.
- Current wound and scar treatment recommendations and guidelines.
- Peer-reviewed and clinical evidence on the therapeutic efficacy of different medication dosage forms, vehicles, excipients, and active ingredients.
- Pharmaceutical formulation strategies and special considerations.
- Innovative and patient-tailored solutions for optimizing patient therapeutic outcome.
The ½ day lab training provides valuable and practical information on preparatory technique, pharmaceutical calculations, workflow optimization, base and dispensing device selection, quality control, and the implementation of innovative technologies in pharmaceutical compounding.
In this lab training, participants will compound three dermatological formulations:
- Topical Wound Ointment
- Topical Scar Gel
- Topical Powder Adhesive Bandage
Pharmacists, Pharmacy Technicians, Physicians, Nurse Practitioners, and other healthcare providers engaged in the treatment of wounds and scars.
- Recognize the need for patient-tailored approaches in the treatment of wounds and scars.
Evaluate peer-reviewed evidence supporting pharmaceutical compounding as an efficacious and often required practice for optimizing personalized medications and patient therapeutic outcome.
Review the different stages of wound healing and understand the progression of non-healing wounds and abnormal scar formation.
Investigate factors that affect wound healing and the challenges they present to treatment.
Describe current clinical recommendations and guidelines on wound and scar assessment and management.
- Investigate formulation aspects of topical wound and scar therapy, including dosage forms, vehicles, excipients, and active ingredients.
Apply skills of reasoning and interpretation in customizing formulations.
Discuss customization opportunities for the pharmaco-treatment of various wound and scar conditions.
- Recognize the limitations of commercial drug products for the treatment of wounds and scars.
Discuss the need for customized medications to address the challenges faced in wound and scar therapy.
Describe the different types of wounds and scars.
Discuss factors that affect wound healing and scar formation.
Review important concepts in topical therapy, including dosage forms, excipients, vehicles and active ingredients.
Compare and contrast the advantages of various excipients and learn how to correctly implement them in compounding.
Practice customizing formulations.
Discuss specific wound and scar conditions, and explore opportunities for customization.
- Recognize different types of wounds and scars, and interpret the stages of wound healing.
- Evaluate the impact of internal and external factors on wound healing.
- Apply evidence-based medical approaches in the assessment, cleansing, dressing, and topical treatment of wounds and scars.
- Utilize empirical and peer-reviewed evidence to support personalized and tailored approaches for the topical treatment of wounds and scars.
This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.
The live activity workbook is copyright © 2018-2019 LP3 Network.
The training will take place at the LP3 Network Facility.
The preferred hotel accommodation will be announced closer to the live date - please check back soon!
AARON SIHOTA, BSc, BSc Pharm, RPh
Aaron Sihota is a primary care pharmacist and is presently a Clinical Instructor at the University of British Columbia (UBC) Faculty of Pharmacy. He is the co-creator of the course on Dermatology, Cosmeceuticals, and Topical Compounding at the UBC Faculty of Pharmacy, which is taught to pharmacology students and dermatologists. He also serves on the Canadian Pharmacists Association (CPhA) Dermatology Review Panel as an author and chapter reviewer for the Compendium of Therapeutics for Minor Ailments (CTMA), and he is a regular skincare columnist for the Pharmacy Practice + Business magazine. Given his keen interest in fostering collaborative care between primary care practitioners and specialists, he has developed multiple accredited healthcare education programs and has taught in several conferences across North America.
|VICTORIA POMPA, BSc.|
AARON SIHOTA, BSc, BSc Pharm, RPh
This activity is eligible for CPE and CME credits. Please check back for details.
CANCELLATION AND REFUND POLICY:
In the event that LP3 Network cancels a course, LP3 Network's sole liability shall be course repayment. In no event shall LP3 Network be responsible for any costs related to travel and/or accommodation. A written request must be sent to LP3 Network Inc. requesting ‘Cancellation without Transfer’ to an alternate live activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. There are no refunds, returns, or transfer requests upon purchase of a home study, digital work book, webinar, and eLearning modules. LP3 NETWORK INC. shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to LP3 NETWORK INC. in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, LP3 NETWORK INC. will not issue any refunds, only transfer to an alternate live activity event date.
The transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity date. Failure to submit the “Transfer Request” at least 14 days prior to the original live activity date will default to the “Cancellation and Refund Policy”. The transfer policy can only be applied one (1) time. Transfer to a new live activity date must be within the current calendar year. Failure to attend the new live activity will result in no refund and will no longer be transferable. Confirmation of the new activity date is subject to approval by LP3 Network based on the number of available seats within the selected live activity. There are no refunds, returns, or transfers upon purchase of the home study.